1,020 filings
Page 16 of 51
D
pzntt8ciy
30 Oct 19
$5M in equity / options / securities to be acquired, sold $5M, 2 investors
4:51pm
8-K
frb3u3gonv vs6x
28 Oct 19
Trovagene Announces $5.0 Million Private Placement PricedAt-the-Market
4:52pm
8-K
dic7r
22 Oct 19
Trovagene Announces Positive Response to Treatment in Phase 1b/2 Trial of Onvansertib in Patients with KRAS-Mutated Metastatic Colorectal Cancer
10:30am
4
hie svgsq8q
3 Oct 19
Trovagene / Mark Erlander ownership change
4:16pm
8-K
25tqzfj4ws
2 Oct 19
Other Events
10:33am
8-K
6vhjd
1 Oct 19
Other Events
10:50am
8-K
w12sinbf
30 Sep 19
Other Events
12:46pm
8-K
t107 umk7o9crj6n
19 Sep 19
Other Events
10:06am
424B3
i07ox73 a4mj
12 Sep 19
Prospectus supplement
4:16pm
EFFECT
6y6l4vibl
11 Sep 19
Notice of effectiveness
12:15am
UPLOAD
bk9 hskpr8vs
6 Sep 19
Letter from SEC
12:00am
CORRESP
8wgqvnsm7hap lttd
6 Sep 19
Correspondence with SEC
12:00am
8-K
mw5q8byrim3f2mo
3 Sep 19
Trovagene to Present at the H.C. Wainwright 21st Annual Global Investment Conference
12:33pm
D
6ace9fl4w0
28 Aug 19
$1.5M in equity / options / securities to be acquired, sold $1.5M, 1 investor
5:24pm
8-K
t0bmpl
26 Aug 19
Other Events
1:50pm
424B5
emq86c25j
21 Aug 19
Prospectus supplement for primary offering
9:42pm
8-K
fme6sxq9j lb7
21 Aug 19
Entry into a Material Definitive Agreement
8:25am
8-K
o7uyiq
15 Aug 19
Other Events
12:00am
8-K
0uv989tx79879p0
8 Aug 19
Trovagene Announces Second Quarter 2019 Results and Highlights
4:53pm